A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00731042|
Recruitment Status : Completed
First Posted : August 8, 2008
Results First Posted : June 17, 2009
Last Update Posted : January 26, 2012
|Condition or disease||Intervention/treatment||Phase|
|Healthy||Drug: Avagard Drug: Purell Surgical Scrub||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||33 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Double (Participant, Outcomes Assessor)|
|Official Title:||A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects|
|Study Start Date :||March 2008|
|Actual Primary Completion Date :||April 2008|
|Actual Study Completion Date :||July 2008|
3M Avagard Surgical and healthcare Personnel Hand Antiseptic with Moisturizers
Topical solution, 6 mL, 6 applications/day for 14 days.
Active Comparator: Purell
Purell Surgical Scrub with Moisturizers
Drug: Purell Surgical Scrub
Topical solution, 4 mL, 6 applications/day for 14 days.
Other Name: Purell Surgical Scrub with Moisturizers
- Change From Baseline in Skin Health, Visual Skin Score (VSS) at 14 Days [ Time Frame: Baseline and 14 days ]Observe VSS score at 14 days, and graded change of skin health from baseline using scale of 0 (normal) - 5 (very scaly).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00731042
|Principal Investigator:||Gary L Grove, PhD||cyberDERM Clinical Research|